Literature DB >> 24343863

Simple diagnosis of STAT1 gain-of-function alleles in patients with chronic mucocutaneous candidiasis.

Yoko Mizoguchi1, Miyuki Tsumura, Satoshi Okada, Osamu Hirata, Shizuko Minegishi, Kohsuke Imai, Nobuyuki Hyakuna, Hideki Muramatsu, Seiji Kojima, Yusuke Ozaki, Takehide Imai, Sachiyo Takeda, Tetsuya Okazaki, Tsuyoshi Ito, Shin'ichiro Yasunaga, Yoshihiro Takihara, Vanessa L Bryant, Xiao-Fei Kong, Sophie Cypowyj, Stéphanie Boisson-Dupuis, Anne Puel, Jean-Laurent Casanova, Tomohiro Morio, Masao Kobayashi.   

Abstract

CMCD is a rare congenital disorder characterized by persistent or recurrent skin, nail, and mucosal membrane infections caused by Candida albicans. Heterozygous GOF STAT1 mutations have been shown to confer AD CMCD as a result of impaired dephosphorylation of STAT1. We aimed to identify and characterize STAT1 mutations in CMCD patients and to develop a simple diagnostic assay of CMCD. Genetic analysis of STAT1 was performed in patients and their relatives. The mutations identified were characterized by immunoblot and reporter assay using transient gene expression experiments. Patients' leukocytes are investigated by flow cytometry and immunoblot. Six GOF mutations were identified, three of which are reported for the first time, that affect the CCD and DBD of STAT1 in two sporadic and four multiplex cases in 10 CMCD patients from Japan. Two of the 10 patients presented with clinical symptoms atypical to CMCD, including other fungal and viral infections, and three patients developed bronchiectasis. Immunoblot analyses of patients' leukocytes showed abnormally high levels of pSTAT1 following IFN-γ stimulation. Based on this finding, we performed a flow cytometry-based functional analysis of STAT1 GOF alleles using IFN-γ stimulation and the tyrosine kinase inhibitor, staurosporine. The higher levels of pSTAT1 observed in primary CD14(+) cells from patients compared with control cells persisted and were amplified by the presence of staurosporine. We developed a flow cytometry-based STAT1 functional screening method that would greatly facilitate the diagnosis of CMCD patients with GOF STAT1 mutations.

Entities:  

Keywords:  CMCD; GOF; STAT1; pSTAT1

Mesh:

Substances:

Year:  2013        PMID: 24343863      PMCID: PMC3958742          DOI: 10.1189/jlb.0513250

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  44 in total

1.  Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.

Authors:  Yoshiyuki Minegishi; Masako Saito; Shigeru Tsuchiya; Ikuya Tsuge; Hidetoshi Takada; Toshiro Hara; Nobuaki Kawamura; Tadashi Ariga; Srdjan Pasic; Oliver Stojkovic; Ayse Metin; Hajime Karasuyama
Journal:  Nature       Date:  2007-08-05       Impact factor: 49.962

2.  STAT3 mutations in the hyper-IgE syndrome.

Authors:  Steven M Holland; Frank R DeLeo; Houda Z Elloumi; Amy P Hsu; Gulbu Uzel; Nina Brodsky; Alexandra F Freeman; Andrew Demidowich; Joie Davis; Maria L Turner; Victoria L Anderson; Dirk N Darnell; Pamela A Welch; Douglas B Kuhns; David M Frucht; Harry L Malech; John I Gallin; Scott D Kobayashi; Adeline R Whitney; Jovanka M Voyich; James M Musser; Cristina Woellner; Alejandro A Schäffer; Jennifer M Puck; Bodo Grimbacher
Journal:  N Engl J Med       Date:  2007-09-19       Impact factor: 91.245

Review 3.  Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines?

Authors:  Anne Puel; Capucine Picard; Sophie Cypowyj; Desa Lilic; Laurent Abel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2010-07-30       Impact factor: 7.486

4.  Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines.

Authors:  Kai Kisand; Anette S Bøe Wolff; Katarina Trebusak Podkrajsek; Liina Tserel; Maire Link; Kalle V Kisand; Elisabeth Ersvaer; Jaakko Perheentupa; Martina Moter Erichsen; Nina Bratanic; Antonella Meloni; Filomena Cetani; Roberto Perniola; Berrin Ergun-Longmire; Noel Maclaren; Kai J E Krohn; Mikulás Pura; Berthold Schalke; Philipp Ströbel; Maria Isabel Leite; Tadej Battelino; Eystein S Husebye; Pärt Peterson; Nick Willcox; Anthony Meager
Journal:  J Exp Med       Date:  2010-02-01       Impact factor: 14.307

5.  Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I.

Authors:  Anne Puel; Rainer Döffinger; Angels Natividad; Maya Chrabieh; Gabriela Barcenas-Morales; Capucine Picard; Aurélie Cobat; Marie Ouachée-Chardin; Antoine Toulon; Jacinta Bustamante; Saleh Al-Muhsen; Mohammed Al-Owain; Peter D Arkwright; Colm Costigan; Vivienne McConnell; Andrew J Cant; Mario Abinun; Michel Polak; Pierre-François Bougnères; Dinakantha Kumararatne; László Marodi; Amit Nahum; Chaim Roifman; Stéphane Blanche; Alain Fischer; Christine Bodemer; Laurent Abel; Desa Lilic; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2010-02-01       Impact factor: 14.307

6.  Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.

Authors:  Joshua D Milner; Jason M Brenchley; Arian Laurence; Alexandra F Freeman; Brenna J Hill; Kevin M Elias; Yuka Kanno; Christine Spalding; Houda Z Elloumi; Michelle L Paulson; Joie Davis; Amy Hsu; Ava I Asher; John O'Shea; Steven M Holland; William E Paul; Daniel C Douek
Journal:  Nature       Date:  2008-03-12       Impact factor: 49.962

7.  A partial form of recessive STAT1 deficiency in humans.

Authors:  Ariane Chapgier; Xiao-Fei Kong; Stéphanie Boisson-Dupuis; Emmanuelle Jouanguy; Diana Averbuch; Jacqueline Feinberg; Shen-Ying Zhang; Jacinta Bustamante; Guillaume Vogt; Julien Lejeune; Eleonore Mayola; Ludovic de Beaucoudrey; Laurent Abel; Dan Engelhard; Jean-Laurent Casanova
Journal:  J Clin Invest       Date:  2009-05-11       Impact factor: 14.808

8.  Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3.

Authors:  Cindy S Ma; Gary Y J Chew; Nicholas Simpson; Archana Priyadarshi; Melanie Wong; Bodo Grimbacher; David A Fulcher; Stuart G Tangye; Matthew C Cook
Journal:  J Exp Med       Date:  2008-07-07       Impact factor: 14.307

9.  Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome.

Authors:  Yoshiyuki Minegishi; Masako Saito; Masayuki Nagasawa; Hidetoshi Takada; Toshiro Hara; Shigeru Tsuchiya; Kazunaga Agematsu; Masafumi Yamada; Nobuaki Kawamura; Tadashi Ariga; Ikuya Tsuge; Hajime Karasuyama
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

10.  Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells.

Authors:  Ludovic de Beaucoudrey; Anne Puel; Orchidée Filipe-Santos; Aurélie Cobat; Pegah Ghandil; Maya Chrabieh; Jacqueline Feinberg; Horst von Bernuth; Arina Samarina; Lucile Jannière; Claire Fieschi; Jean-Louis Stéphan; Catherine Boileau; Stanislas Lyonnet; Guillaume Jondeau; Valérie Cormier-Daire; Martine Le Merrer; Cyrille Hoarau; Yvon Lebranchu; Olivier Lortholary; Marie-Olivia Chandesris; François Tron; Eleonora Gambineri; Lucia Bianchi; Carlos Rodriguez-Gallego; Simona E Zitnik; Julia Vasconcelos; Margarida Guedes; Artur Bonito Vitor; Laszlo Marodi; Helen Chapel; Brenda Reid; Chaim Roifman; David Nadal; Janine Reichenbach; Isabel Caragol; Ben-Zion Garty; Figen Dogu; Yildiz Camcioglu; Sanyie Gülle; Ozden Sanal; Alain Fischer; Laurent Abel; Birgitta Stockinger; Capucine Picard; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2008-07-07       Impact factor: 14.307

View more
  25 in total

Review 1.  Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies.

Authors:  Roshini S Abraham; Geraldine Aubert
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

Review 2.  Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind.

Authors:  Bertrand Boisson; Pierre Quartier; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2015-01-31       Impact factor: 7.486

3.  Increased STAT1 Amounts Correlate with the Phospho-STAT1 Level in STAT1 Gain-of-function Defects.

Authors:  Andrea R Bernasconi; Judith Yancoski; Mariana Villa; Matías M Oleastro; Miguel Galicchio; Jorge G Rossi
Journal:  J Clin Immunol       Date:  2018-10-09       Impact factor: 8.317

4.  Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation.

Authors:  Katja G Weinacht; Louis-Marie Charbonnier; Fayhan Alroqi; Ashley Plant; Qi Qiao; Hao Wu; Clement Ma; Troy R Torgerson; Sergio D Rosenzweig; Thomas A Fleisher; Luigi D Notarangelo; Imelda C Hanson; Lisa R Forbes; Talal A Chatila
Journal:  J Allergy Clin Immunol       Date:  2017-01-27       Impact factor: 10.793

5.  Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants.

Authors:  Reiko Kagawa; Ryoji Fujiki; Miyuki Tsumura; Sonoko Sakata; Shiho Nishimura; Yuval Itan; Xiao-Fei Kong; Zenichiro Kato; Hidenori Ohnishi; Osamu Hirata; Satoshi Saito; Maiko Ikeda; Jamila El Baghdadi; Aziz Bousfiha; Kaori Fujiwara; Matias Oleastro; Judith Yancoski; Laura Perez; Silvia Danielian; Fatima Ailal; Hidetoshi Takada; Toshiro Hara; Anne Puel; Stéphanie Boisson-Dupuis; Jacinta Bustamante; Jean-Laurent Casanova; Osamu Ohara; Satoshi Okada; Masao Kobayashi
Journal:  J Allergy Clin Immunol       Date:  2016-12-20       Impact factor: 10.793

Review 6.  Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.

Authors:  Jacinta Bustamante; Stéphanie Boisson-Dupuis; Laurent Abel; Jean-Laurent Casanova
Journal:  Semin Immunol       Date:  2014-10-26       Impact factor: 11.130

7.  Novel Gain-of-Function Mutation in Stat1 Sumoylation Site Leads to CMC/CID Phenotype Responsive to Ruxolitinib.

Authors:  Tariq Al Shehri; Kimberly Gilmour; Florian Gothe; Sam Loughlin; Shahnaz Bibi; Andrew D Rowan; Angela Grainger; Thivytra Mohanadas; Andrew J Cant; Mary A Slatter; Sophie Hambleton; Desa Lilic; Timothy R Leahy
Journal:  J Clin Immunol       Date:  2019-09-11       Impact factor: 8.317

Review 8.  Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies.

Authors:  Jolan E Walter; Jocelyn R Farmer; Zsofia Foldvari; Troy R Torgerson; Megan A Cooper
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Nov - Dec

Review 9.  Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy.

Authors:  Satoshi Okada; Takaki Asano; Kunihiko Moriya; Stephanie Boisson-Dupuis; Masao Kobayashi; Jean-Laurent Casanova; Anne Puel
Journal:  J Clin Immunol       Date:  2020-08-27       Impact factor: 8.317

10.  Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype.

Authors:  Julie Toubiana; Satoshi Okada; Julia Hiller; Matias Oleastro; Macarena Lagos Gomez; Juan Carlos Aldave Becerra; Marie Ouachée-Chardin; Fanny Fouyssac; Katta Mohan Girisha; Amos Etzioni; Joris Van Montfrans; Yildiz Camcioglu; Leigh Ann Kerns; Bernd Belohradsky; Stéphane Blanche; Aziz Bousfiha; Carlos Rodriguez-Gallego; Isabelle Meyts; Kai Kisand; Janine Reichenbach; Ellen D Renner; Sergio Rosenzweig; Bodo Grimbacher; Frank L van de Veerdonk; Claudia Traidl-Hoffmann; Capucine Picard; Laszlo Marodi; Tomohiro Morio; Masao Kobayashi; Desa Lilic; Joshua D Milner; Steven Holland; Jean-Laurent Casanova; Anne Puel
Journal:  Blood       Date:  2016-04-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.